Associated Papers
Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity.
Hong TH et al.
Journal for Immunotherapy of Cancer, 2020
33077514 (PubMed )
Supplement: jitc-2020-001199supp002.pdf
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor Virulence.
Ibrahimpasic T et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2017
Tumor suppressor properties of the splicing regulatory factor RBM10.
Hernández J et al.
Rna Biology, 2016
Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site.
Tessier SJ et al.
Bmc Research Notes, 2015
RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation.
Bechara EG et al.
Molecular Cell, 2013
Select a paper to view details